During the past decade, Haematologie und Internistische Onkologie Praxis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Haematologie und Internistische Onkologie Praxis" are "Lymphoma" (2 trials). Many other conditions were trialed in "Haematologie und Internistische Onkologie Praxis" in a lesser frequency.

Most popular intervention types in "Haematologie und Internistische Onkologie Praxis" are "Biological" (2 trials), "Drug" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials), "radiation therapy" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Haematologie und Internistische Onkologie Praxis" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Haematologie und Internistische Onkologie Praxis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Haematologie und Internistische Onkologie Praxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haematologie und Internistische Onkologie Praxis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".